Drug Database
Back to search

France· FR:61143073

NOVOPTINE 0,1 mg/0,4 ml, collyre en récipient unidose

A medicinal product containing chlorure de cétylpyridinium, registered in France by SIFI (ITALIE).

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNOVOPTINE 0,1 mg/0,4 ml, collyre en r…ATC—REGISTER NO.FR:61143073PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorure de cétylpyridiniumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORURE DE CÉTYLPYRIDINIUM
Manufacturer
SIFI (ITALIE)
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400935147455
    10 récipient(s) unidose(s) polyéthylène de 0,4 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Chlorure de cétylpyridinium in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlorure de cétylpyridinium products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Austria · Halset
  • Czechia · Halset, Neoseptolete Třešeň
  • Germany · Anginetten, Halstabletten - Akute Hals- Und Rachenhilfe Zur Anwendung Bei Erwachsenen Und Kindern Ab 3 Jahren
  • United Kingdom (Northern Ireland) · Antiseptic, First Aid Antiseptic
  • Italy · Cetilsan, Cetilsan Senza Zucchero
  • Malta · Cetilsan Sugar Free
  • Norway · Pyrisept
  • Poland · Halset, Septolete Junior
  • Slovenia · Neoseptolete Z Okusom Divje Češnje, Neoseptolete Z Okusom Limone

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bfad141b-f622-4dbf-9b04-06950191f6d3
GET /v1/drugs/bfad141b-f622-4dbf-9b04-06950191f6d3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61143073",
  "date_amm": "1992-02-21",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CHLORURE DE CÉTYLPYRIDINIUM",
  "statut_amm": "Autorisation active",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "collyre",
  "voies_administration": "ophtalmique",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about chlorure de cétylpyridinium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console